Skip to main content
TipRanks
Go Ultimate75% OFF

Prelude Therapeutics (PRLD) Q4 2025 Earnings Report

196 Followers

PRLD Q4 2025 EPS Results

Actual EPS
-$0.20
Consensus EPS
-$0.03
Beat/Miss
Missed by -$0.17
One Year Ago EPS
-$0.37

PRLD Q4 2025 Revenue Results

Actual Revenue
$5.64M
Expected Revenue
$20.50M
Beat/Miss
Missed by -$14.86M
YoY Revenue Growth
+41.00%

Earnings Announcement Details

Quarter
Q4 2025
Date
03/10/2026
Time
Before Open
Conference Call
Tuesday, March 10, 2026
PRLD Upcoming Earnings

Prelude Therapeutics's next earnings date is estimated for March 16, 2027, based on past reporting schedules.

Q4 2025 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

PRLD Earnings History

PRLD earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 16, 20272026 (Q4)―--0.2――
Nov 05, 20262026 (Q3)0.01--0.26―
Aug 19, 20262026 (Q2)-0.20-0.14-0.4165.85% (+0.27)
May 12, 20262026 (Q1)-0.25-0.13-0.4269.05% (+0.29)
Mar 10, 20262025 (Q4)-0.03-0.20-0.3745.95% (+0.17)
Nov 12, 20252025 (Q3)-0.37-0.26-0.4339.53% (+0.17)
Aug 14, 20252025 (Q2)-0.44-0.41-0.4610.87% (+0.05)
May 06, 20252025 (Q1)-0.47-0.42-0.420.00% (+0.00)
Mar 10, 20252024 (Q4)-0.46-0.37-0.4517.78% (+0.08)
Nov 06, 20242024 (Q3)-0.47-0.43-0.454.44% (+0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed